6 results match your criteria: "Huangshi Traditional Chinese Medicine Hospital[Affiliation]"
Inflamm Bowel Dis
November 2024
Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Fibrosis characterized by intestinal strictures is a common complication of Crohn's disease (CD), without specific antifibrotic drugs, which usually relies on surgical intervention. The transcription factor XBP1, a key component of endoplasmic reticulum (ER) stress, is required for degranulation of mast cells and linked to PAR2 activation and fibrosis. Many studies have confirmed that naringin (NAR) can inhibit ER stress and reduce organ fibrosis.
View Article and Find Full Text PDFHeliyon
August 2023
Department of Pathology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, People's Republic of China.
Background: Immunogenic cell death (ICD) triggers adaptive immune responses that aid in anticancer therapy. However, the significance of ICD-associated genes (ICDAGs) in clinical applications and their potential impact on the tumor microenvironment (TME) remains unclear.
Methods: The TCGA cohort was divided into different ICD clusters using the method of Consensus clustering.
Clin Transl Oncol
January 2023
Department of Acupuncture, Huangshi Traditional Chinese Medicine Hospital, 6 Square Road, Huangshi, 435000, Hubei Province, China.
Purpose: Colorectal cancer (CRC) is a malignant tumor. Oxaliplatin (OXA) can inhibit cancer-associated fibroblasts (CAFs)-induced cancer progression. This study sought to explore the mechanism of OXA in CAFs-induced CRC development.
View Article and Find Full Text PDFThorax
July 2022
Institute for Disaster Management and Reconstruction, Sichuan University, Chengdu, Sichuan, People's Republic of China
Objectives: To investigate superiority of a telerehabilitation programme for COVID-19 (TERECO) over no rehabilitation with regard to exercise capacity, lower limb muscle strength (LMS), pulmonary function, health-related quality of life (HRQOL) and dyspnoea.
Design: Parallel-group randomised controlled trial with 1:1 block randomisation.
Setting: Three major hospitals from Jiangsu and Hubei provinces, China.
Medicine (Baltimore)
March 2021
Huangshi Traditional Chinese Medicine Hospital, Huangshi, Hubei, China.
Objective: To compare and evaluate the clinical effects on patients with poststroke insomnia of various acupuncture and acupuncture-related therapies.
Methods: In order to analyze the direct and indirect evidence from related studies, we used network meta-analysis (NMA). In order to collect randomized controlled trials (RCTs) of acupuncture and related therapies in the treatment of poststroke insomnia, 3 English and 4 Chinese databases were searched.
Risk Manag Healthc Policy
November 2020
Department of Infectious Diseases, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, People's Republic of China.
Background: Infection surveillance and risk factor analysis are among the most important prerequisites for the prevention and treatment of nosocomial bacteria infections, which are the demands for both infected and non-infected patients.
Purpose: To explore the risk factors for nosocomial bacterial infection of patients with COVID-19, and further to provide a theoretical basis for scientific prevention and control of nosocomial bacterial infection.
Methods: Between 10 January 2020 and 9 March 2020, we collected data of 212 patients with COVID-19 and then explored the influence of age, gender, length of stay, use of ventilator, urinary catheterization, central venous catheterization, white blood cell (WBC) count and procalcitonin on the nosocomial bacterial infection of patients with COVID-19 by a retrospective study.